EUVIMEDEUVIMED entdecken
Crossref

Disulfidptosis and Enzymatic‐Therapy Augmented Cuproptosis via Adding Spear and Discarding Shield Strategy

Yong Liu, Xiao-Qiong Li, Hang Gao, Qiao Yu, Yuxi Long, Bin Kang, Xueli Zhao, Jing-Juan Xu iD

Small · 2025

DOI: 10.1002/smll.202506138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2025. Verfasst von Yong Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210023, Chi…. Hauptthemen laut MEDLINE: Copper, Apoptosis, Enzyme Therapy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cuproptosis, a new copper‐dependent cell death modality, is increasingly acknowledged for its crucial role in anticancer therapy. It is still hampered by weak activation and the overexpression of cellular self‐protective components, such as glutathione (GSH) and copper efflux transporter ATPase. Here, the Cu 2 O‐based nanoactivators (CGH NAs) are prepared to enhance the “offensive” of cuproptosis toward tumor cells by “adding spears (Cu + )” and “discarding shields (GSH, ATPase)” simultaneously. Initially, the glucose oxidase (GOx)‐mediated gluconic acid production can promote the release of Cu⁺ from Cu 2 O for effective cuproptosis activation. Meanwhile, disulfidptosis, a recently found programmed cell death, can be induced by CGH NAs, which inhibit the cystine‐to‐cysteine metabolic pathway and thereby block copper chelator GSH biosynthesis. Next, Cu 2 O‐induced self‐cascade enzymatic reactions (OXD, SOD, and POD) are first achieved, which lead to significant mitochondrial dysfunction. Benefiting from the dual inhibition of mitochondrial metabolism and GOx‐induced glycolysis, the provision of ATP is fundamentally blocked, thereby further downregulating the ATPase to prevent the efflux of copper ions. Collectively, the “adding spear and discarding shield” strategy dramatically inhibits primary tumor growth in vivo (73.5%). This work first demonstrates disulfidptosis‐augmented cuproptosis, and will also provide unique inspiration for regulating both the positive and negative directions in cuproptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CopperApoptosisEnzyme TherapyHumansGlucose OxidaseGlutathioneAnimalsCell Line, TumorMitochondriaDisulfidptosis

Stichwörter der Autor:innen

copper(I) oxide (Cu2O)cuproptosisdisulfidptosisself‐cascade enzymatic therapy

Substanzen

CopperGlucose OxidaseGlutathione

Autor:innen und Institutionen

  • State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210023, China.
  • College of Chemistry and Molecular Engineering, Zhengzhou University, Zhengzhou, 450001, China.

ORCID-Profile: Jing-Juan Xu

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • NIGMS NIH HHS
  • Excellent Research Program of Nanjing University
  • Fundamental Research Funds for the Central Universities
  • National Key Research and Development Program of China

Zitieren

APA

Liu, Y., Li, X. Q., Gao, H., Yu, Q., Long, Y., Kang, B., Zhao, X., & Xu, J. J. (2025). Disulfidptosis and Enzymatic‐Therapy Augmented Cuproptosis via Adding Spear and Discarding Shield Strategy. Small. https://doi.org/10.1002/smll.202506138

Vancouver

Liu Y, Li XQ, Gao H, Yu Q, Long Y, Kang B, et al. Disulfidptosis and Enzymatic‐Therapy Augmented Cuproptosis via Adding Spear and Discarding Shield Strategy. Small. 2025. doi:10.1002/smll.202506138

BibTeX
@article{Liu2025,
  author = {Liu, Yong and Li, Xiao-Qiong and Gao, Hang and Yu, Qiao and Long, Yuxi and Kang, Bin and Zhao, Xueli and Xu, Jing-Juan},
  title = {Disulfidptosis and Enzymatic‐Therapy Augmented Cuproptosis via Adding Spear and Discarding Shield Strategy},
  journal = {Small},
  year = {2025},
  doi = {10.1002/smll.202506138}
}
Kostenlos starten →